We are live on ! Find out more
HDIM

Hanson & Doremus Investment Management Portfolio holdings

AUM $983M
1-Year Est. Return 34.23%
This Fund
S&P 500
This Quarter Est. Return
-11.5%
1 Year Est. Return
+34.23%
3 Year Est. Return
+80.83%
5 Year Est. Return
+81.33%
10 Year Est. Return
+253.13%
AUM
$277M
AUM Growth
-$43M
Cap. Flow
-$1.78M
Cap. Flow %
-0.64%
Top 10 Hldgs %
38.69%
Holding
477
New
18
Increased
56
Reduced
151
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 12.66%
2 Healthcare 9.32%
3 Industrials 7.02%
4 Financials 6.77%
5 Communication Services 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
51
Weyerhaeuser
WY
$18B
$1.25M 0.45%
57,062
-377
-0.7% -$10K
AZN icon
52
AstraZeneca
AZN
$246B
$1.22M 0.44%
16,067
-1,106
-6% -$86.4K
WHR icon
53
Whirlpool
WHR
$2.84B
$1.2M 0.43%
11,261
+2,305
+26% +$261K
OKE icon
54
Oneok
OKE
$57.7B
$1.17M 0.42%
21,587
+1,251
+6% +$77.7K
QRVO icon
55
Qorvo
QRVO
$8.53B
$1.14M 0.41%
18,808
TIP icon
56
iShares TIPS Bond ETF
TIP
$14.7B
$1.08M 0.39%
9,880
-12,263
-55% -$1.34M
GDX icon
57
VanEck Gold Miners ETF
GDX
$27.5B
$1.07M 0.39%
50,719
-3,569
-7% -$70K
GLD icon
58
SPDR Gold Trust
GLD
$143B
$1.07M 0.39%
8,825
+545
+7% +$63.3K
GE icon
59
GE Aerospace
GE
$382B
$1.07M 0.39%
29,394
-12,210
-29% -$551K
WU icon
60
Western Union
WU
$2.2B
$1.06M 0.38%
62,185
-5,036
-7% -$91.6K
IBB icon
61
iShares Biotechnology ETF
IBB
$9.81B
$1M 0.36%
10,374
+67
+0.7% +$7.11K
EWBC icon
62
East-West Bancorp
EWBC
$18.2B
$995K 0.36%
22,850
-2,432
-10% -$126K
COP icon
63
ConocoPhillips
COP
$151B
$975K 0.35%
15,640
-269
-2% -$18.3K
MCK icon
64
McKesson
MCK
$105B
$958K 0.35%
8,676
+377
+5% +$47K
SRCL
65
DELISTED
Stericycle Inc
SRCL
$947K 0.34%
25,816
-7,480
-22% -$351K
TEX icon
66
Terex
TEX
$7.74B
$931K 0.34%
33,770
SPYX icon
67
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.86B
$907K 0.33%
44,655
+1,215
+3% +$26.5K
BAX icon
68
Baxter International
BAX
$14.3B
$894K 0.32%
13,588
-322
-2% -$21.6K
HBI
69
DELISTED
Hanesbrands
HBI
$885K 0.32%
70,609
-19,741
-22% -$307K
CBU icon
70
Community Bank
CBU
$3.41B
$882K 0.32%
15,128
-280
-2% -$16.9K
DIS icon
71
Walt Disney
DIS
$179B
$852K 0.31%
7,767
+1,736
+29% +$197K
TRV icon
72
Travelers Companies
TRV
$78.3B
$845K 0.31%
7,053
-215
-3% -$26.9K
SPY icon
73
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$844K 0.31%
3,377
-12
-0.4% -$3.24K
SYF icon
74
Synchrony
SYF
$25.5B
$832K 0.3%
35,462
+3,638
+11% +$98.4K
ABT icon
75
Abbott
ABT
$190B
$828K 0.3%
11,445
-222
-2% -$15.6K

Similar funds

Hanson & Doremus Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Hanson & Doremus Investment Management held 477 positions worth $277M, down 13% from $320M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Hanson & Doremus Investment Management's Q4 2018 filing shows 18 new, 56 increased, 151 reduced and 26 closed positions. Its largest new stake was abrdn Asia-Pacific Income Fund: 6,679 shares worth $155K. The largest sale was Schwab International Equity ETF, an estimated $5.26M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Hanson & Doremus Investment Management's largest Q4 2018 buy was abrdn Asia-Pacific Income Fund: 6,679 shares worth $155K.
  • Hanson & Doremus Investment Management added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $7.27M increase.
  • Hanson & Doremus Investment Management's biggest Q4 2018 reduction was Schwab International Equity ETF, cutting an estimated $5.26M.
  • Hanson & Doremus Investment Management fully exited Vodafone in Q4 2018, selling an estimated $1.88M.
  • Hanson & Doremus Investment Management's ten largest holdings make up 39% of its $277M portfolio in Q4 2018.
  • Hanson & Doremus Investment Management opened 18 new positions and closed 26 in Q4 2018.
  • Hanson & Doremus Investment Management's portfolio value fell 13% quarter-over-quarter to $277M.

Based on Hanson & Doremus Investment Management's 13F filing for Q4 2018, filed 31 Jan 2019.